News from lexicon pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 22, 2014, 01:01 ET

Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

 Ipsen (Euronext: IPN; ADR: IPSEY) and Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that they have entered into an exclusive...

Sep 11, 2014, 16:30 ET

Lexicon Announces A Publication In The American Diabetes Association's Journal, Diabetes Care

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced a publication in the online edition of the American Diabetes Association's journal,...

Sep 04, 2014, 07:00 ET

Lexicon To Present At The Morgan Stanley 2014 Global Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Morgan Stanley 2014 Global Healthcare...

Aug 08, 2014, 08:00 ET

Lexicon To Present At The 2014 Wedbush Life Sciences Management Access Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 2014 Wedbush Life Sciences Management...

Aug 07, 2014, 07:00 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Second Quarter Financial Results

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Aug 05, 2014, 07:00 ET

Lexicon To Report Second Quarter 2014 Financial Results On August 7, 2014

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will...

Jul 09, 2014, 07:00 ET

Lexicon And JDRF Collaborate For Phase 2 Clinical Trial Of LX4211 In Type 1 Diabetes

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D)...

Jul 07, 2014, 16:15 ET

Lexicon Announces Appointment of Lonnel Coats as President and Chief Executive Officer

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lonnel Coats has been appointed president and chief executive officer...

Jun 14, 2014, 13:15 ET

Lexicon Presents LX4211 Data at American Diabetes Association Meeting

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), presented data at the 74th Scientific Sessions of the American Diabetes Association (ADA) in San...

May 30, 2014, 17:00 ET

Lexicon To Present At The Jefferies 2014 Global Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Jefferies 2014 Global Healthcare...

May 09, 2014, 07:00 ET

Lexicon To Present At The 2014 Bank of America Merrill Lynch Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 2014 Bank of America Merrill Lynch...

May 08, 2014, 06:00 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 First Quarter Financial Results

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today...

May 05, 2014, 07:00 ET

Lexicon To Report First Quarter 2014 Financial Results On May 8, 2014

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will...

Apr 14, 2014, 06:00 ET

LX4211 Achieves Positive Results In Type 1 Diabetes Clinical Trial

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today positive, top-line results in a Phase 2 clinical trial of LX4211 in type 1...

Apr 03, 2014, 07:00 ET

Lexicon To Present At The 2014 Needham Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Needham Healthcare Conference on...

Feb 28, 2014, 07:00 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Fourth Quarter And Full Year Financial Results

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Feb 20, 2014, 07:00 ET

Lexicon to Report Fourth Quarter and Year End 2013 Financial Results on February 28, 2014

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will...

Feb 03, 2014, 06:00 ET

Lexicon To Present At The BIO CEO And Investor Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the BIO CEO & Investor...

Jan 13, 2014, 06:00 ET

Lexicon Announces Focus On Late-Stage Development Programs And Preparation For Commercialization

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today it is focusing its resources on its late-stage drug development programs, principally...

Jan 08, 2014, 06:00 ET

Lexicon To Present At The J.P. Morgan Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur Sands, M.D., Ph.D., President and Chief Executive Officer, will...